Key Laboratory of Functional Polymer Materials of Ministry Education, Institute of Polymer Chemistry, College of Chemistry , Nankai University , Tianjin 300071 , China.
ACS Appl Mater Interfaces. 2019 Oct 30;11(43):39648-39661. doi: 10.1021/acsami.9b15118. Epub 2019 Oct 21.
can cause a multitude of inflammations in humans. Due to its ability to form biofilm, the bacteria show durable resistance to drugs. Herein, we developed a heteromultivalent ligand-decorated nanotherapeutic inspired by living system for inhibition of antibiotic-resistant bacterial pneumonia. The nanotherapeutic with a heteromultivalent glycomimetic shell can specifically recognize to inhibit its biofilm formation and protect native cells from bacterial infection; the rate of biofilm inhibition was up to 85%. The nanotherapeutic with a bioresponsive hydrophobic core can protonate and control drug release in the microenvironment of bacterial infections. By utilizing these properties, the nanotherapeutics can effectively penetrate the internal structure of biofilms to release the drug, dispersing the biofilm by over 80% under laser irradiation. In vivo bioinspired nanotherapeutics have the potential to efficiently inhibit antibiotic-resistant -induced pneumonia. Collectively, we expect biomimicking systems to be the next generation of prevention and treatment as integrated antibacterial agents against .
能够在人体内引起多种炎症。由于其形成生物膜的能力,该细菌对药物表现出持久的耐药性。在此,我们受生命系统的启发,开发了一种异多价配体修饰的纳米治疗药物,用于抑制抗生素耐药性肺炎球菌感染。具有异多价糖模拟外壳的纳米治疗药物可以特异性识别并抑制其生物膜形成,保护天然细胞免受细菌感染;生物膜抑制率高达 85%。具有生物响应性疏水性内核的纳米治疗药物可以在细菌感染的微环境中质子化并控制药物释放。利用这些特性,纳米治疗药物可以有效地穿透生物膜的内部结构释放药物,在激光照射下,生物膜的分散度超过 80%。体内仿生纳米治疗药物具有有效抑制抗生素耐药性肺炎球菌诱导的肺炎的潜力。总的来说,我们期望仿生系统成为下一代预防和治疗策略,作为一种针对 的整合抗菌药物。